Cannabics Pharmaceuticals Inc. (OTC Pink: CNBX), developer of cannabinoid-based treatments and therapies,partnered with Wana Products in mid-June to distribute its innovative extended release technology designed for medical marijuana. With varying concentrations of THCs and CBDs, the company’s capsules represent the next generation in the evolution of marijuana for the medical community, enabling patients to consume exactly what they need.

Cannabics has tested the capsules with over 100 patients in Israel where medical research on cannabis has been legal since 2008. Test subjects found the capsule to be effective at reducing pain, eliminating nausea, and improving sleep, appetite, and mood. Based on this feedback, the company is undertaking a more comprehensive clinical trial in partnership with Rambam Hospital in Haifa, with results expected over the coming quarters.

The new capsules address major concerns of cannabis patients, including the problem of reaching the initial high soon after administration, which can cause uncomfortable...